AVM BIOTECHNOLOGY
AVM is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a productive history including 47 patents and 4 discoveries in clinical trials. The company's lead drug AVM0703, an innovative formulation of dexamethasone, when given at suprapharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 could be the first choice for no-option cancer, autoimmunity, and infectious disease. AVM Biotechnology has a Scientific Advisory Board including well-respected leaders in cancer and immunology.
AVM BIOTECHNOLOGY
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2008-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.avmbiotech.com
Total Employee:
11+
Status:
Active
Contact:
+1 206 906 9922
Email Addresses:
[email protected]
Total Funding:
24.35 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Content Delivery Network Font Awesome Global Site Tag
Similar Organizations
Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - AVM Biotechnology
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - AVM Biotechnology
National Institutes of Health
National Institutes of Health investment in Grant - AVM Biotechnology
Official Site Inspections
http://www.avmbiotech.com Semrush global rank: 11.56 M Semrush visits lastest month: 156
- Host name: 150.152.196.35.bc.googleusercontent.com
- IP address: 35.196.152.150
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "AVM Biotechnology"
AVM Biotechnology
Our Story. AVM Biotechnology is a clinical-stage company, founded by Theresa Deisher, Ph.D. The company is developing AVM0703, a proprietary and innovative therapeutic option for โฆSee details»
AVM Biotechnology - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 206 906 9922 AVM is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a โฆSee details»
AVM Biotechnology Company Profile | Management and โฆ
[email protected]: AVM Biotechnology Top Competitors. Company Employees Revenue Top technologies; Boehringer Ingelheim Venture Fund. 33: $6.8 M: Taiga Biotechnologies Inc. โฆSee details»
AVM BIOTECHNOLOGY, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AVM BIOTECHNOLOGY, INC. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
AVM Biotechnology - Overview, News & Similar companies
AVM Biotechnology contact info: Phone number: (206) 906-9922 Website: www.avmbiotech.com What does AVM Biotechnology do? AVM Biotechnology is a clinical stage company โฆSee details»
AVM Biotech - The Org
AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment โฆSee details»
AVM Biotech - Company Profile - Tracxn
Nov 27, 2024 AVM Biotech - Small molecule and biologics for regenerative medicine, oncology, and fully human biologics. Raised a total funding of $12.8M over 9 rounds from 3 investors. โฆSee details»
AVM Biotechnology | Seattle, WA, USA Startup - Gust
Website avmbiotech.com; Company Summary AVMโs unique technology and mission present a clear advantage over the current technologies that rely on aborted fetal material. i) Biologic based manipulation of stem cell distribution โฆSee details»
Nextsource | Company Profile | AVM Biotechnology
Explore the company profile of AVM Biotechnology (avmbiotech.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Working At AVM Biotechnology: Company Overview and Culture
Avmbiotech.com. Organization Type. Private. CEO. Joe Luminiello. Social Media. AVM Biotechnology is a biotechnology company that discovers, develops, and commercializes cell โฆSee details»
AVM Biotechnology - Craft
AVM Biotechnology has 5 employees at their 1 location and $8.74 m in total funding,. See insights on AVM Biotechnology including office locations, competitors, revenue, financials, executives, โฆSee details»
AVM Biotechnology - F6S
Avmbiotech.com About AVM Biotechnology AVM Biotechnology is advancing the development of game-changing cellular therapy focused technologies for immuno-oncology, regenerative โฆSee details»
AVM Biotechnology LLC Overview - Salary.com
Discover essential details about AVM Biotechnology LLC, including address, contact, and journey of our company's evolution.See details»
AVM Biotechnology
A treating physician may submit questions or requests regarding the proigram to AVM Biotechnology directly, by phone (+1-206-906-9922), or e-mail โฆSee details»
Ave Maria Biotechnology LLC (Ave Maria Biotechnology LLC) - ่ฏ โฆ
Contact [email protected]. (Photo: Business Wire) โWe are excited to have been selected, after competitive review, to be a 2023-2024 showcase company for the NCIโs SBIR Investor โฆSee details»
AVM Biotechnology Careers and Employment | Indeed.com
The workplace culture is an anxious one with confusing but competitive internal organization and scattered, frantic directions. Intern in Seattle, WA. 5.0. on August 14, 2017. Focused and โฆSee details»
AVM Biotechnology
Advantages of AVM0703. Durable Clinical Response in Relapsed/Refractory Non-Hodgkinโs Lymphoma (NHL)/Leukemia including T-cell Lymphoma โ 28-day responseSee details»
AVM Biotechnology Email Format | avmbiotech.com Emails
The most common AVM Biotechnology email format is [first_initial][last] (ex. [email protected]), which is being used by 98.0% of AVM Biotechnology work email โฆSee details»
AVM Biotechnology
AVM Biotechnology News. ASCO 2024 AVM0703 Poster #7077: Durable complete response and overall survival in patients with heavily pretreated, poor-prognosis non-Hodgkin lymphoma to โฆSee details»